Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Wolf

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Bone Marrow Transplantation|September 1, 2000
High-dose chemotherapy (CTM) for breast cancerL E Damon, J L Wolf, H S Rugo, et al.
Pharmaceutical Research|April 17, 2001
Pharmacokinetics and safety of an anti-vascular endothelial growth factor aptamer (NX1838) following injection into the vitreous humor of rhesus monkeysD W Drolet, J Nelson, C E Tucker, et al.
Lung Cancer (Amsterdam, Netherlands)|January 12, 2023
The value of prognostic and predictive parameters in early-stage lung adenocarcinomas: A comparison between biopsies and resectionsJ L Wolf, T E Trandafir, F Akram, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 4, 2000
High-dose chemotherapy and hematopoietic stem cell rescue for breast cancer: experience in CaliforniaL E Damon, W W Hu, K E Stockerl-Goldstein, et al.
Blood|March 1, 1983
Bone marrow ablation followed by allogeneic marrow grafting during first complete remission of acute nonlymphocytic leukemiaS J Forman, W E Spruce, M J Farbstein, et al.
The New England Journal of Medicine|May 8, 1980
Bone-marrow ablation and allogeneic marrow transplantation in acute leukemiaK G Blume, E Beutler, K J Bross, et al.
Leukemia|May 29, 2010
Bortezomib, dexamethasone, cyclophosphamide and lenalidomide combination for newly diagnosed multiple myeloma: phase 1 results from the multicenter EVOLUTION studyS K Kumar, I Flinn, S J Noga, et al.
Bone Marrow Transplantation|September 23, 2014
Delayed hematopoietic recovery after auto-SCT in patients receiving arsenic trioxide-based therapy for acute promyelocytic leukemia: a multi-center analysisG N Mannis, A C Logan, A D Leavitt, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Bone Marrow Transplantation|September 1, 2000
High-dose chemotherapy (CTM) for breast cancerL E Damon, J L Wolf, H S Rugo, et al.
Pharmaceutical Research|April 17, 2001
Pharmacokinetics and safety of an anti-vascular endothelial growth factor aptamer (NX1838) following injection into the vitreous humor of rhesus monkeysD W Drolet, J Nelson, C E Tucker, et al.
Lung Cancer (Amsterdam, Netherlands)|January 12, 2023
The value of prognostic and predictive parameters in early-stage lung adenocarcinomas: A comparison between biopsies and resectionsJ L Wolf, T E Trandafir, F Akram, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 4, 2000
High-dose chemotherapy and hematopoietic stem cell rescue for breast cancer: experience in CaliforniaL E Damon, W W Hu, K E Stockerl-Goldstein, et al.
Blood|March 1, 1983
Bone marrow ablation followed by allogeneic marrow grafting during first complete remission of acute nonlymphocytic leukemiaS J Forman, W E Spruce, M J Farbstein, et al.
The New England Journal of Medicine|May 8, 1980
Bone-marrow ablation and allogeneic marrow transplantation in acute leukemiaK G Blume, E Beutler, K J Bross, et al.
Leukemia|May 29, 2010
Bortezomib, dexamethasone, cyclophosphamide and lenalidomide combination for newly diagnosed multiple myeloma: phase 1 results from the multicenter EVOLUTION studyS K Kumar, I Flinn, S J Noga, et al.
Bone Marrow Transplantation|September 23, 2014
Delayed hematopoietic recovery after auto-SCT in patients receiving arsenic trioxide-based therapy for acute promyelocytic leukemia: a multi-center analysisG N Mannis, A C Logan, A D Leavitt, et al.
Pageof 6